Skip to content
★ Sign in to follow
IS

Inhalation Sciences Sweden AB Stock: price and insider trades · Sweden

ISIN SE0009983893SE·Health Care

No insider purchase over the last 90 days. The latest, by Jan Hellqvist, was filed 30 May 2023.

Inhalation Sciences Sweden AB: what insiders have been doing

Inhalation Sciences Sweden AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. Inhalation Sciences Sweden AB has had no insider filing for more than a year; the last one goes back to 31 July 2023.

The full history, which starts in 2018, counts 5 purchases against no sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€160,374
5 ops. · all time
Sell Volume
n/a
n/a

Financial data

as of FY 2025

FY ended December 2025 · cache

SEK 0.08
Analyst consensus
·
Income statement
RevenueSEK 3M
Gross profitSEK 2.6M85% margin
EBITDA-SEK 9.7M-319% margin
Net income-SEK 10.2M-103.1% margin
Valuation
P/Book0.7x
Beta-0.08
Balance sheet & cash
Free Cash Flow-SEK 10.8M
Profitability & ownership
ROE-90.0%
ROA-47.3%
% insiders8.1%
% institutions21.7%
Last declaration on 31 July 2023
Declarations16 total
  • ●
    StyrelseordförandeExecutives
    499,997 SEK0FI-SE
    138,888 shares@ SEK 3.60AktieISIN SE0009983893FI:csv-e064d18aaf03f3f1747d
  • ●
    Styrelseledamot, Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
    299,999 SEK0FI-SE
    83,333 shares@ SEK 3.60BTA (betald tecknad aktie)ISIN SE0020053718FI:csv-24e52877d2cd25b57e2a
  • ▲
    StyrelseledamotExecutives
    50,000 SEK0FI-SE
    13,889 shares@ SEK 3.60AktieISIN SE0020053718FI:csv-1dbc2889633e49db077d
    Canonical exit: 28 Aug 2023 (T+90)
  • ●
    Verkställande direktör (VD)Executives
    49,997 SEK0FI-SE
    13,888 shares@ SEK 3.60BTA (betald tecknad aktie)ISIN SE0020053718FI:csv-da0ec9c7ea763bbf7236
  • ●
    StyrelseledamotExecutives
    252,000 SEK0FI-SE
    70,000 shares@ SEK 3.60BTA (betald tecknad aktie)ISIN SE0020053718FI:csv-d953c7f523462deb24f4
  • ▲
    StyrelseordförandeExecutives
    2M SEK0FI-SE
    150,000 shares@ SEK 10.00AktieISIN SE0009983893FI:csv-dcf6e1d655d3c3c9541b
    Canonical exit: 11 Nov 2021 (T+90)
  • ◆
    Styrelseledamot/suppleantExecutives
    55,000 SEK0FI-SE
    50,000 shares@ SEK 1.1090.9% of flowTeckningsoptionFI:csv-2fc412ef2b40e5b4d046
  • ◆
    VDExecutives
    55,000 SEK0FI-SE
    50,000 shares@ SEK 1.1035.5% of flowTeckningsoptionFI:csv-e5dd6e0b93c32d489742
  • ◆
    StyrelseordförandeExecutives
    440,000 SEK0FI-SE
    400,000 shares@ SEK 1.10100.0% of flowTeckningsoptionFI:csv-fb88a0364dba43dfca8b
  • ◆
    VDExecutives
    5,500 SEK0FI-SE
    5,000 shares@ SEK 1.103.5% of flowTeckningsoptionFI:csv-50fee188c9b740a6c020
  • ◆
    Styrelseledamot/suppleantExecutives
    165,000 SEK0FI-SE
    150,000 shares@ SEK 1.10100.0% of flowTeckningsoptionFI:csv-174a19f9c6ccc470692a
  • ◆
    Styrelseledamot/suppleantExecutives
    5,500 SEK0FI-SE
    5,000 shares@ SEK 1.109.1% of flowTeckningsoptionFI:csv-cf25e973dff63218ce0d
  • ▲
    VDExecutives
    0FI-SE
    86,200 shares0KöpoptionISIN SE0009983893FI:csv-ed55d2c5b3b20ae46c2b
    Canonical exit: 25 Dec 2019 (T+90)
  • ▲
    VDExecutives
    13,140 SEK23FI-SE
    1,800 shares@ SEK 7.308.4% of flowAktieISIN SE0009983893FI:csv-380c58bbb05f0c775c03
    Canonical exit: 25 Dec 2019 (T+90)
  • ▲
    VDExecutives
    82,500 SEK27FI-SE
    11,000 shares@ SEK 7.5052.6% of flowAktieISIN SE0009983893FI:csv-152008974d7c3e19a05f
    Canonical exit: 25 Dec 2019 (T+90)
  • ●
    Styrelseledamot/suppleantExecutives
    0FI-SE
    643,128 shares0AktieISIN SE0009983893FI:csv-73f1057281b9df5ff788

16 of 16 declarations

About Inhalation Sciences Sweden AB

Inhalation Sciences Sweden AB is a company focused on developing technologies for drug inhalation. It is listed on the XSTO market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations